in

Fragment-Based Drug Discovery Market is estimated to be worth around USD 1.6 billion by 2030

Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery

Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030.”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

  • A detailed review of the overall landscape of fragment-based drug discovery library and service providers.
  • Elaborate profiles of the companies providing libraries and services for fragment-based drug discovery (shortlisted on the basis of the service portfolio and number of fragment screening techniques offered).
  • An analysis of the partnerships that have been established in the recent past.
  • A detailed analysis on acquisition targets.
  • An insightful competitiveness analysis of fragment-based drug discovery library and service providers.
  • An analysis highlighting the cost saving potential associated with the use of fragment-based drug discovery approach.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Type of Technique

  • X-ray Crystallography
  • Nuclear Magnetic Resonance
  • Surface Plasmon Resonance
  • Other Screening Techniques

Type of Service

  • Library Screening
  • Fragment Screening
  • Fragment Optimization

End User

  • Industry Players
  • Non-Industry Players

Key Geographical Region 

  • North America (US and Canada)
  • Europe (UK, France, Germany, Spain, Italy, and rest of Europe)
  • Asia-Pacific (China, Japan, India, and rest of Asia-Pacific / rest of the world)

Key companies covered in the report

  • 2bind
  • Charles River Laboratories
  • ChemAxon
  • ComInnex
  • Creative Biolabs
  • Creative Biostructure
  • CRELUX
  • Domainex
  • Evotec
  • Red Glead Discovery
  • SARomics Biostructures
  • Shanghai ChemPartner
  • Sygnature Discovery
  • Vernalis Research

Request for Customization: 

https://www.rootsanalysis.com/reports/309/request-customization.html    

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

This post was created with our nice and easy submission form. Create your post!

What do you think?

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0
Bitcoin Price Struggles Below $48k As Market Declines

Bitcoin Price Struggles Below $48k As Market Declines

The significance of Bitcoin Centrists and why more Bitcoiners are transitioning from maximalism to Centrism

Bitcoiners From 2010 Have Made Over $692k More In Profits Than Uber Seed Investors ⋆ ZyCrypto